MedTrace Logo

Berlin-Brandenburg Pregnancy Cohort

NCT03313024 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1580

Last updated 2018-08-14

No results posted yet for this study

Summary

This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.

Conditions

  • Preeclampsia
  • Pregnancy Complications
  • Diabetes Mellitus in Pregnancy

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-26
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03313024 on ClinicalTrials.gov